Canterbury DHB


AIDS-related Lymphoma (ARL)

The prognosis of ARL has improved with developments of infusional regimens, the use of rituximab and transplantation in relapsed disease. Important differences remain in this group of patients. Special attention to prophylaxis of infection is required. See Dunleavy, al. (2012). "How I treat HIV-associated lymphoma." Blood 119: 3245-55.

About this Canterbury DHB document (9649):

Document Owner:

Peter Ganly (see Who's Who)

Last Reviewed:

December 2021

Next Review:

December 2024


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 9649